Development of new antituberculous drugs based on bacterial virulence factors interfering with host cytokine networks

Author:

Tomioka Haruaki,Tatano Yutaka,Sano Chiaki,Shimizu Toshiaki

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Reference118 articles.

1. World Health Organization. Global tuberculosis control. A short update to the 2009 report. 2009. (http://www.who.int/tb/publications/global_report/2009/update/tbu_9.pdf

2. World Health Organization. A ministerial meeting of high M/XDR-TB burden countries: the key bottlenecks hampering the prevention and scale-up of M/XDR-TB control and patient care. 2009. (http://www.who.int/tb/challenges/mdr/bottlenecks/bottlenecks_full_version.pdf)

3. New tuberculosis drug development. How can we do better?;O’Brien;Am J Respir Crit Care Med,1998

4. Antituberculosis drugs: ten years of research;Janin;Bioorg Med Chem,2006

5. Current status of some antituberculosis drugs and the development of new antituberculous agents with special reference to their in vitro and in vivo antimicrobial activities;Tomioka;Curr Pharm Des,2006

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3